Personalizing Ovarian Cancer- Knowing Your Genetics - Beth Karlan, MD - UCLAMDChat

Explore the latest advancements in ovarian cancer treatment and genetic testing in this informative 26-minute lecture by UCLA gynecologic oncologist Dr. Beth Karlan. Gain insights into the diverse nature of ovarian cancer, its origins, and the importance of tumor molecular profiling for improved patient outcomes. Discover the role of genetic testing in identifying hereditary ovarian cancer and learn about targeted therapeutic options, including PARP inhibitors and immunotherapy. Understand the significance of family testing and risk-reducing interventions for individuals with genetic predispositions. Delve into key takeaways and participate in a Q&A session to enhance your knowledge of personalized approaches to ovarian cancer management.

Introduction
Objectives
Ovarian Cancer is not one disease
Most ovarian cancers dont even begin in the ovary
Ovarian cancer testing
Survival curve
Somatic mutations
Tumor molecular profiling
Survival curves
PARP inhibitors
Genetic testing
Family testing
Angelina Jolie
Risk reducing interventions
Risk reducing salpingo oophorectomy
Key takeaways
Summary
Questions